Advocacy

Endocrine Insider - November 4, 2010

ENDO_INSIDER_ONLINE_BANNER_400_Pixels
 
 
Republican-Controlled House May Impact Spending and Health Reform
The results of the mid-term congressional election leave future action on many of the priorities of The Endocrine Society in question. Voters gave control of the House of Representatives to the Republicans...

 
Medicare Final Rule Retains Problematic Policies but Addresses Concerns Raised by Society
The Centers for Medicare and Medicaid Services released the 2011 Medicare Physician Fee Schedule Final Rule, in which administrators respond to stakeholder comments on the proposed rule...

 
Society Endorses Bone Health Conference on Emerging Areas of Systems-Based Interventions
Experts in bone health will convene on December 9 & 10, 2010 in Washington, DC for a state-of-the-art conference, “Best Practices in Systems-Based Interventions to Reduce the Burden of Fractures.” The conference represents a national effort to bring together practitioners...

 
FDA Requires Warnings on Risk for Class of Prostate Cancer Drugs
The U.S. Food and Drug Administration (FDA) has asked manufacturers to add new warnings to labeling of gonadotropin-releasing hormone (GnRH) agonists, which are used to treat men with prostate cancer...